Proxalutamide shows promise as potential COVID-19 treatment

At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between androgen receptors-;which bind to hormones like testosterone–and SARS-CoV-2 viral infection.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

A new chapter may have begun in the exciting story of “immune reset” therapy for difficult-to-treat autoimmune diseases, with a patient with severe refractory lupus

September 5, 2024

Illumina board agrees to spin off Grail, as divestment plans proceed

Illumina said Monday afternoon that its board of directors had approved a spin-off of its cancer test subsidiary Grail, signaling that a nearly four-year-long, $8

June 3, 2024

Medicare drug price negotiation didn’t benefit Biden — but it may help Harris

WASHINGTON — When Vice President Kamala Harris takes the stage at the Democratic National Convention next week, she’ll have a fresh policy achievement to tout:

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.